A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways-Reference-Cited by-同舟云学术

A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways

Published:2018-01 Issue: Volume:269 Page:405-422
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Yang Dayun,Luo Wensong,Wang Jichuang,Zheng Min,Liao Xin-Hua,Zhang Nan,Lu Wenxian,Wang Long,Chen Ai-Zheng,Wu Wen-Guo,Liu Hekun,Wang Shi-Bin,Zhou Xiao Zhen,Lu Kun Ping^ORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Fujian Province

Innovation of Science and Technology, Fujian Province

Outstanding Young Scientific Research Personnel Training Plan in Colleges and Universities of Fujian Province

Fujian Provincial Health and Family Planning Commission Fund

Research Foundation of Educational Commission of Fujian Province

Collaborative Innovation Center for Stem Cells Translational Medicine

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference81 articles.

1. Targeted cancer therapies;Aggarwal;Nat. Rev. Drug Discov.,2010

2. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

3. Principles of cancer therapy: oncogene and non-oncogene addiction;Luo;Cell,2009

4. Cancer genome landscapes;Vogelstein;Science,2013

5. Tumor heterogeneity in hepatocellular carcinoma: facing the challenges;Lu;Liver Cancer,2016

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

2. Oridonin, a small molecule inhibitor of cancer stem cell with potent cytotoxicity and differentiation potential;European Journal of Pharmacology;2024-07

3. Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery;Science Signaling;2024-06-18

4. Recent advances of Pin1 inhibitors as potential anticancer agents;Bioorganic Chemistry;2024-03

5. pH-sensitive niosomes for ATRA delivery: A promising approach to inhibit Pin1 in high-grade serous ovarian cancer;International Journal of Pharmaceutics;2024-01